BEAN Partners advises Innovative Edge

BEAN Partners
Innovative Edge



BEAN Partners Successfully Executes Sale of Innovative Edge to Lumanity

London, UK — 31 March 2022

The HealthTech team at BEAN Partners, led by Damian Woodward and Tom Imlay, advised the shareholders of Innovative Edge (“IE”) on the sale of their business.

Lumanity has now released details about its recent acquisition of Innovative Edge, a leading UK based provider of pharmaceutical product launch software and services.

Successful product launches are vital to biopharma companies achieving commercial success, enabling patients worldwide to quickly and easily access medical advances.

IE is the launch excellence partner for world-leading pharmaceutical companies—from ‘Top 20’ pharma to fast-growing biotechs. IE specialises in supporting global, regional and local product launches, with deep expertise in providing end-to-end support. Utilising its proprietary Launch EcoSystem™ solution, which combines expertise in building plans and launch team capabilities with IE's collaborative launch management platform Ignite™, the company has supported hundreds of product launches, helping its customers to chart, implement and monitor the key elements required for a successful launch.

Lumanity has been formed by bringing together the expertise and capabilities of several exceptional health and medical organisations. It is backed by Arsenal Capital Partners, a leading middle market private equity firm that specialises in building transformative healthcare businesses. With offices in North America, the UK, Europe, and Asia (and work conducted in over 50 countries) Lumanity has 1,200+ experts working with the top pharmaceutical and biotech companies worldwide. The highly complementary addition of IE fully aligns with its commitment to partnering with life sciences companies, offering end-to-end capabilities that combine commercialisation strategy with launch implementation.

Steve Marsh, Founder and CEO of IE:

“We are thrilled to join this exciting and rapidly growing organization. Our combined capabilities will enable us to build comprehensive launch support programs that work across functions and geographies, and that stretch from early strategy through to tactical implementation.”

Jon Williams, CEO of Lumanity:

"We are delighted to welcome IE to the Lumanity family, further enhancing our asset optimization and commercialization capabilities...that will improve patient health by accelerating and optimizing access to medical advances.”

BEAN Partners acted as advisor to IE throughout the transaction process, from the planning stages through to deal execution and due diligence. Legal advice to the IE shareholders was provided by Richard Wilkey and Pearse Sheehan of Harrison Clarke Rickerbys.

Involvement from BEAN Partners proved critical to achieving the desired sale outcome for the shareholders, while also supporting the achievement of an effective ‘strategic fit’ between the parties to this acquisition.

Steve Marsh, Founder and CEO of IE:

“The partnership approach and support from the BEAN Partners team during the whole process was invaluable. Their involvement significantly impacted the outcome from the sale for me and the other shareholders of IE and it was a pleasure to work with them.”

Damian Woodward, Principal and Co-Founder of BEAN Partners:

“We have seen the HealthTech space ‘hotting up’ over the last few years 
with regard to M&A and we have a strong focus in this area, having built a dedicated team. We are very pleased with the strategic fit that was achieved 
in this transaction and the impact we were able to have on the outcome for 
the IE shareholders.”
[email protected]